A group of researchers at the University of Tennessee Graduate School of Medicine in Knoxville has created technology that provides non-invasive detection of amyloidosis, a disease known to occur in Type 2 diabetes, myeloma, rheumatoid arthritis, Alzheimer’s and other fatal or debilitating diseases. Currently there is no detection for amyloidosis available in the U.S., and the median survival rate is four years.
On Friday, Jan. 29, DuPont Danisco Cellulosic Ethanol LLC (DDCE) and University of Tennessee/Genera Energy LLC will hold a grand opening celebration for one of the nation’s first cellulosic ethanol demo plants, and the only one dedicated to converting both agricultural residue and bioenergy crops to fuel ethanol. The facility, located in Vonore, Tenn., has initiated start-up and commissioning and will begin producing ethanol in mid-January.
At least for the moment, the world’s fastest supercomputer is devoted to solving scientific questions that may save the planet — climate change, renewable energy, new medicines — rather than advances in nuclear weapons that might blow it up.